National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 72600 [2016-25340]

Download as PDF 72600 Federal Register / Vol. 81, No. 203 / Thursday, October 20, 2016 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HOMELAND SECURITY National Institutes of Health U.S. Customs and Border Protection National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting [CBP Dec. No. 16–18] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01). Date: November 17, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: J. Bruce Sundstrom, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G11A, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, 240–669–5045, sundstromj@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 14, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–25340 Filed 10–19–16; 8:45 am] BILLING CODE 4140–01–P Electronic Visa Update System (EVUS) Requirements: Identification of the People’s Republic of China (PRC) as an EVUS Country and Designation of Maximum Validity B–1, B–2, and B–1/ B–2 Visas as Designated Visa Categories AGENCY: U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice. SUMMARY: In this Federal Register, DHS is publishing a final rule titled ‘‘Establishment of the Electronic Visa Update System (EVUS)’’ (hereafter ‘‘EVUS Final Rule’’), amending 8 CFR part 215, subpart B, to establish the Electronic Visa Update System and to specify certain requirements. According to the rule, nonimmigrant aliens who hold a passport issued by an identified country containing a U.S. nonimmigrant visa of a designated category will be required to provide biographic and other information to DHS by enrolling in EVUS to maintain the validity of those visas. The EVUS final rule specifies that the Secretary of Homeland Security, in consultation with the Secretary of State, may identify countries and designate nonimmigrant visa categories for purposes of the EVUS requirements and that notice of identified countries and designated nonimmigrant visa categories will be published in the Federal Register. Through this notice, the Secretary of Homeland Security, after consultation with the Secretary of State, identifies the People’s Republic of China (PRC) as an EVUS country and designates B–1, B–2, and B–1/B–2 visas issued without restriction for the maximum validity period, which is generally 10 years,1 as designated visa categories when the visas are contained in a passport issued by the PRC. DATES: This identification and designation is effective October 20, 2016. mstockstill on DSK3G9T082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Suzanne Shepherd, Office of Field Operations, Suzanne.M.Shepherd@ cbp.dhs.gov or (202) 344–2073. SUPPLEMENTARY INFORMATION: 1 This includes visas issued for more than nine years and all replacement visas issued to correct errors in the original instance. VerDate Sep<11>2014 16:40 Oct 19, 2016 Jkt 241001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Background In this Federal Register, DHS is publishing a final rule titled ‘‘Establishment of the Electronic Visa Update System (EVUS)’’ amending 8 CFR part 215, subpart B, to establish the Electronic Visa Update System. EVUS is an online information update system that allows for the collection of biographic and other information from nonimmigrant aliens who hold a passport issued by an identified country containing a U.S. nonimmigrant visa of a designated category. See EVUS Final Rule. Nonimmigrant aliens subject to these regulations must periodically enroll in EVUS and obtain a notification of compliance prior to travel to the United States. As discussed in the Department of State’s parallel rule, ‘‘Visa Information Update Requirements under the Electronic Visa Update System (EVUS),’’ also published in this Federal Register, individuals subject to the EVUS requirements must comply with the EVUS regulations in 8 CFR part 215, subpart B, in order to maintain the validity of their visas of a designated category. As specified in 8 CFR 215.22, and explained in the EVUS Final Rule, the Secretary of Homeland Security, in the Secretary’s discretion and in consultation with the Secretary of State, may identify countries (‘‘EVUS countries’’) whose passport holders will be subject to the EVUS regulations, if the passport contains a U.S. nonimmigrant visa of a designated category, and designate applicable visa categories. The regulations state that notice of identified countries and designated visa categories will be published in the Federal Register. See 8 CFR 215.22 and 8 CFR 215.23(c). This announcement provides such a notice. Identification and Designation Pursuant to 8 CFR 215.22, the Secretary, following consultation with the Secretary of State, identifies the People’s Republic of China (PRC) as an EVUS country and designates all B–1, B–2, and B–1/B–2 visas issued without restriction for maximum validity, which generally will be 10 years, but includes visas issued for more than nine years and all replacement visas issued to correct errors in the original visa, as designated visa categories when the visas are contained in a passport issued by the PRC. B nonimmigrant visas, often referred to as ‘‘visitor visas,’’ are issued to individuals seeking to travel and be admitted to the United States temporarily for business (visa category B–1); for tourism or pleasure, (visa E:\FR\FM\20OCN1.SGM 20OCN1

Agencies

[Federal Register Volume 81, Number 203 (Thursday, October 20, 2016)]
[Notices]
[Page 72600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25340]



[[Page 72600]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Pilot Clinical Trials to Eliminate 
the Latent HIV Reservoir (U01).
    Date: November 17, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: J. Bruce Sundstrom, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G11A, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, 240-669-5045, 
sundstromj@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 14, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-25340 Filed 10-19-16; 8:45 am]
BILLING CODE 4140-01-P